semaglutide shortage ending The Is Ending: What's Next For Compounded Drugs? US judge upholds FDA's removal

Until recently, GLP-1s were only indicated and marketed for the management of type II diabetes

Always inject into subcutaneous tissuethe fatty layer under your skinnot into muscle

An early 2025 report noted that Red Rock Pharmacy issued a notice to its prescriber network regarding a former employee who had been contacting Red Rock customers to promote compounded semaglutide and tirzepatide from a competitor pharmacy at lower prices, a situation in which Red Rock was the victim of the solicitation, not the subject of any enforcement action

This is an important stage, as incomplete or inconsistent data will stall acceptance

Distinguishing between appropriate frequency from increased fluid intake and pathological frequency from bladder inflammation requires paying attention to accompanying symptoms, particularly burning, urgency, and changes in urine appearance or smell

doi:10.1016/j.xops.2023.100341 31